NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing ...Middle East

Accumulated proceeds of $3 million including the initial closing held in March 2025 ZÜRICH, June 30, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (NASDAQ: NLSP) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on developing therapies for central nervous...

Read More Details
Finally We wish PressBee provided you with enough information of ( NLS Pharmaceutics and Kadimastem Announce Pricing and Closing of $1 Million Equity Financing )

Also on site :

• Occupation conducts military exercise on border with Jordan after completion of "Gilead" Division
• Numbrix 9 - June 30
• 21-year-old Baloch student becomes another victim of extrajudicial killing by Pakistani forces